Tien Liang BioTech Co., Ltd.
4127
Rank in Stocks
#22801
Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New... Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New Taipei City, Taiwan, is a pharmaceutical enterprise involved in the development, manufacturing, and global distribution of a diverse array of health and medicinal products. The company's offerings include traditional Chinese medicine (TCM) formulations, predominantly in pill form. These remedies address a broad spectrum of conditions, such as internal organ deficiencies (e.g., liver and kidney), various forms of musculoskeletal and neuropathic discomfort (including low back pain, joint pain, rheumatism, gout, and neuralgia), and common ailments like dizziness, digestive issues (constipation, hemorrhoids), respiratory symptoms (colds, bronchitis, coughs), and skin conditions (athlete's foot). Additionally, Tien Liang BioTech provides a range of Western pharmaceutical products. This segment features topical applications like ointments, pain relief gels, soreness sprays, and transdermal pain patches, alongside oral preparations such as tablets and capsules. The portfolio also includes specialized items like hair removal creams. Beyond pharmaceuticals, the company extends its reach into general consumer health and personal care. These offerings comprise products designed for body relaxation and comfort, items to alleviate post-exercise discomfort, oral hygiene products, and various soaps.
Share Price
$1.08
Last synced: 2026-11-10
Market Cap
$49.52M
Change (1 day)
3.05%
Change (1 year)
7.33%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Tien Liang BioTech Co., Ltd. (4127)
Category
Healthcare
Operating Margin for Tien Liang BioTech Co., Ltd. (4127)
Operating Margin as of November 2026 TTM: 0.87%
According to Tien Liang BioTech Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 0.87%. At the end of 2025 the company had an operating margin of -3.15%.
Operating Margin history for Tien Liang BioTech Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.87% | -127.62% |
| 2025 | -3.15% | -2,200.00% |
| 2024 | 0.15% | -96.62% |
| 2023 | 4.44% | -61.59% |
| 2022 | 11.56% | 30.47% |
| 2021 | 8.86% | -181.89% |
| 2020 | -10.82% | 8.63% |
| 2019 | -9.96% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -77.69% |
DE
|
|
| 19.68% | -77.38% |
DE
|
|
| 13.26% | -84.76% |
JP
|
|
| 17.08% | -80.37% |
CH
|
|
| 14.92% | -82.85% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Tien Liang BioTech Co., Ltd.'s operating margin
What is Tien Liang BioTech Co., Ltd.'s operating margin?
Tien Liang BioTech Co., Ltd.'s operating margin is 0.87%, as of Nov 2026.
What was Tien Liang BioTech Co., Ltd.'s operating margin in 2025?
In 2025, Tien Liang BioTech Co., Ltd.'s operating margin was -3.15%, compared with 0.15% in 2024.
How has Tien Liang BioTech Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Tien Liang BioTech Co., Ltd.'s operating margin was highest in 2022 (11.56%) and lowest in 2020 (-10.82%).
How does Tien Liang BioTech Co., Ltd.'s operating margin compare with similar companies?
Tien Liang BioTech Co., Ltd.'s operating margin (0.87%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.